5 Unstoppable Stocks That Will Make You Richer

Page 5 of 5

1. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Price Target Upside: 36.01%

Year-to-date Gain as of April 11: 29.35%

Number of Hedge Fund Holders: 46

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a Massachusetts-based company that discovers and develops unique RNA-based therapeutics-based treatments for both rare and infectious diseases. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tops our list of unstoppable stocks that will make you richer and has gained 29.35% year-to-date, as of April 11.

In the fourth quarter of 2023, 46 hedge funds had stakes in Sarepta Therapeutics, Inc. (NASDAQ:SRPT), with total positions worth $1.559 billion. With 4.344 million shares worth $418,934 million, VenBio Select Advisor is the most significant shareholder in the company as of Q4 2023.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has a consensus rating of Strong Buy as per the 16 Wall Street analysts that have covered it over the past three months. The average price target of $169.67 implies an upside of 36.01% from the current levels, as of April 11.

Follow Sarepta Therapeutics Inc. (NASDAQ:SRPT)

Should you invest $1,000 in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) right now?

Before you buy stock in SRPT, consider this:

The Insider Monkey Quarterly Newsletter just identified what we believe are the 14 best stocks for investors to buy now… and SRPT wasn’t one of them. The 14 stocks that made the cut could produce monster returns in the next few months.

Quarterly Newsletter is your easy-to-follow blueprint for building a winning portfolio.  It includes stock picks from billionaires, regular updates from hedge fund investor letters, and 14 fresh stock picks each quarter. The Quarterly Newsletter service has more than doubled the return of S&P 500 since 2014.

See the 14 stocks

Disclosure: None. You can also look at the 11 Oversold Value Stocks To Buy Now and 30 Unique Business Ideas for Women.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5